$556 Million is the total value of Ghost Tree Capital, LLC's 128 reported holdings in Q1 2015. The portfolio turnover from Q4 2014 to Q1 2015 was 122.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XBI | New | SPDR SERIES TRUSTput | $45,100,000 | – | 200,000 | +100.0% | 8.11% | – |
| ZBH | Buy | ZIMMER HLDGS INC | $23,504,000 | +140.4% | 200,000 | +132.0% | 4.23% | -9.9% |
| B108PS | Buy | ACTAVIS PLC | $20,834,000 | +362.5% | 70,000 | +300.0% | 3.75% | +73.3% |
| New | ENDO HEALTH SOLUTIONS INCnote 1.750% 4/1 | $16,146,000 | – | 180,000 | +100.0% | 2.90% | – | |
| CYH | New | COMMUNITY HEALTH SYS INC NEW | $15,684,000 | – | 300,000 | +100.0% | 2.82% | – |
| NUVA | Buy | NUVASIVE INC | $14,716,000 | +246.7% | 320,000 | +255.6% | 2.65% | +30.0% |
| PBYI | Buy | PUMA BIOTECHNOLOGY INC | $14,166,000 | +149.5% | 60,000 | +100.0% | 2.55% | -6.5% |
| ZSPH | New | ZS PHARMA INC | $13,886,000 | – | 330,000 | +100.0% | 2.50% | – |
| ZLTQ | Buy | ZELTIQ AESTHETICS INC | $13,874,000 | +210.7% | 450,000 | +181.2% | 2.49% | +16.4% |
| CELG | New | CELGENE CORP | $13,834,000 | – | 120,000 | +100.0% | 2.49% | – |
| PTLA | Buy | PORTOLA PHARMACEUTICALS INC | $13,666,000 | +221.7% | 360,000 | +140.0% | 2.46% | +20.6% |
| SAGE | New | SAGE THERAPEUTICS INC | $12,056,000 | – | 240,000 | +100.0% | 2.17% | – |
| DYAX | Buy | DYAX CORP | $11,728,000 | +156.6% | 700,000 | +115.4% | 2.11% | -3.8% |
| MMSI | Buy | MERIT MED SYS INC | $11,550,000 | +788.5% | 600,000 | +700.0% | 2.08% | +232.9% |
| MRK | New | MERCK & CO INC NEW | $11,496,000 | – | 200,000 | +100.0% | 2.07% | – |
| T107PS | Buy | WRIGHT MED GROUP INC | $10,320,000 | +63.4% | 400,000 | +70.2% | 1.86% | -38.8% |
| BDX | New | BECTON DICKINSON & CO | $10,052,000 | – | 70,000 | +100.0% | 1.81% | – |
| GNCA | New | GENOCEA BIOSCIENCES INC | $9,962,000 | – | 840,000 | +100.0% | 1.79% | – |
| NUVA | New | NUVASIVE INCcall | $9,198,000 | – | 200,000 | +100.0% | 1.65% | – |
| ADHD | New | ALCOBRA LTD | $9,008,000 | – | 1,600,000 | +100.0% | 1.62% | – |
| AAVL | Buy | AVALANCHE BIOTECHNOLOGIES IN | $8,914,000 | +32.1% | 220,000 | +76.0% | 1.60% | -50.5% |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $8,724,000 | +141.3% | 70,000 | +75.0% | 1.57% | -9.6% |
| SNSS | New | SUNESIS PHARMACEUTICALS INC | $8,576,000 | – | 3,500,000 | +100.0% | 1.54% | – |
| CPHD | Buy | CEPHEID | $8,536,000 | +57.7% | 150,000 | +50.0% | 1.54% | -40.9% |
| ALNY | Buy | ALNYLAM PHARMACEUTICALS INC | $8,354,000 | +56.6% | 80,000 | +45.5% | 1.50% | -41.3% |
| A | New | AGILENT TECHNOLOGIES INCcall | $8,310,000 | – | 200,000 | +100.0% | 1.49% | – |
| RVNC | New | REVANCE THERAPEUTICS INC | $8,292,000 | – | 400,000 | +100.0% | 1.49% | – |
| GWPH | New | GW PHARMACEUTICALS PLCads | $8,202,000 | – | 90,000 | +100.0% | 1.48% | – |
| ABBV | New | ABBVIE INC | $8,196,000 | – | 140,000 | +100.0% | 1.47% | – |
| AAVL | New | AVALANCHE BIOTECHNOLOGIES INcall | $8,104,000 | – | 200,000 | +100.0% | 1.46% | – |
| EXAS | New | EXACT SCIENCES CORP | $7,708,000 | – | 350,000 | +100.0% | 1.39% | – |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $7,616,000 | +205.1% | 700,000 | +133.3% | 1.37% | +14.3% |
| ACHN | New | ACHILLION PHARMACEUTICALS IN | $7,396,000 | – | 750,000 | +100.0% | 1.33% | – |
| PTCT | Buy | PTC THERAPEUTICS INC | $7,302,000 | +66.0% | 120,000 | +41.2% | 1.31% | -37.8% |
| TXMD | Buy | THERAPEUTICSMD INC | $7,260,000 | +156.2% | 1,200,000 | +88.4% | 1.30% | -4.0% |
| BLUE | Buy | BLUEBIRD BIO INC | $7,246,000 | +163.3% | 60,000 | +100.0% | 1.30% | -1.4% |
| FLML | Buy | FLAMEL TECHNOLOGIES SAsponsored adr | $7,192,000 | +29.2% | 400,000 | +23.1% | 1.29% | -51.6% |
| INGN | New | INOGEN INC | $7,038,000 | – | 220,000 | +100.0% | 1.26% | – |
| VTAE | New | VITAE PHARMACEUTICALS INC | $7,026,000 | – | 600,000 | +100.0% | 1.26% | – |
| DBVT | Buy | DBV TECHNOLOGIES S Asponsored adr | $7,008,000 | +222.9% | 300,000 | +275.0% | 1.26% | +21.0% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $6,828,000 | +444.5% | 670,000 | +644.4% | 1.23% | +104.0% |
| ENTL | New | ENTELLUS MED INC | $6,570,000 | – | 300,000 | +100.0% | 1.18% | – |
| RDUS | New | RADIUS HEALTH INC | $6,174,000 | – | 150,000 | +100.0% | 1.11% | – |
| DSCO | New | DISCOVERY LABORATORIES INC N | $5,950,000 | – | 5,000,000 | +100.0% | 1.07% | – |
| PTX | New | PERNIX THERAPEUTICS HLDGS IN | $5,346,000 | – | 500,000 | +100.0% | 0.96% | – |
| RXDX | New | IGNYTA INC | $4,976,000 | – | 500,000 | +100.0% | 0.90% | – |
| LBIO | New | LION BIOTECHNOLOGIES INC | $4,844,000 | – | 400,000 | +100.0% | 0.87% | – |
| TTPH | New | TETRAPHASE PHARMACEUTICALS I | $4,764,000 | – | 130,000 | +100.0% | 0.86% | – |
| AGTC | New | APPLIED GENETIC TECHNOL CORP | $4,668,000 | – | 233,500 | +100.0% | 0.84% | – |
| FPRX | New | FIVE PRIME THERAPEUTICS INC | $4,570,000 | – | 200,000 | +100.0% | 0.82% | – |
| LOXO | New | LOXO ONCOLOGY INC | $4,358,000 | – | 350,000 | +100.0% | 0.78% | – |
| EPZM | New | EPIZYME INC | $4,320,000 | – | 230,000 | +100.0% | 0.78% | – |
| BDSI | New | BIODELIVERY SCIENCES INTL INcall | $4,200,000 | – | 400,000 | +100.0% | 0.76% | – |
| ACAD | New | ACADIA PHARMACEUTICALS INC | $3,911,000 | – | 120,000 | +100.0% | 0.70% | – |
| ACHC | New | ACADIA HEALTHCARE COMPANY IN | $3,911,000 | – | 120,000 | +100.0% | 0.70% | – |
| CLDN | Buy | CELLADON CORP | $3,788,000 | +385.0% | 200,000 | +400.0% | 0.68% | +81.6% |
| UNIS | New | UNILIFE CORP NEW | $3,610,000 | – | 900,000 | +100.0% | 0.65% | – |
| ADXS | Sell | ADVAXIS INC | $3,610,000 | +6.5% | 250,000 | -40.9% | 0.65% | -60.1% |
| PODD | New | INSULET CORP | $3,336,000 | – | 100,000 | +100.0% | 0.60% | – |
| ASMB | Buy | ASSEMBLY BIOSCIENCES INC | $3,310,000 | +547.7% | 250,000 | +284.6% | 0.60% | +142.9% |
| KIN | New | KINDRED BIOSCIENCES INC | $1,436,000 | – | 201,000 | +100.0% | 0.26% | – |
| BIOL | Buy | BIOLASE INC | $1,212,000 | +53.6% | 600,000 | +100.0% | 0.22% | -42.5% |
| OCRX | Buy | OCERA THERAPEUTICS INC | $1,178,000 | +48.0% | 250,000 | +100.0% | 0.21% | -44.5% |
| GBIM | Buy | GLOBEIMMUNE INC | $1,012,000 | +468.5% | 137,946 | +487.0% | 0.18% | +114.1% |
| XOMA | New | XOMA CORP DEL | $524,000 | – | 144,000 | +100.0% | 0.09% | – |
| CPRX | Exit | CATALYST PHARM PARTNERS INC | $0 | – | -250,000 | -100.0% | -0.36% | – |
| WMGIZ | Exit | WRIGHT MED GROUP INCright 03/01/2019 | $0 | – | -185,000 | -100.0% | -0.42% | – |
| ASPX | Exit | AUSPEX PHARMACEUTICALS INC | $0 | – | -20,000 | -100.0% | -0.50% | – |
| SNN | Exit | SMITH & NEPHEW PLCspdn adr new | $0 | – | -30,000 | -100.0% | -0.53% | – |
| TNDM | Exit | TANDEM DIABETES CARE INC | $0 | – | -100,000 | -100.0% | -0.61% | – |
| RPTP | Exit | RAPTOR PHARMACEUTICAL CORP | $0 | – | -150,000 | -100.0% | -0.76% | – |
| BLCM | Exit | BELLICUM PHARMACEUTICALS INC | $0 | – | -75,000 | -100.0% | -0.83% | – |
| Exit | IMMUNOGEN INC | $0 | – | -300,000 | -100.0% | -0.88% | – | |
| ACHN | Exit | ACHILLION PHARMACEUTICALS INcall | $0 | – | -150,000 | -100.0% | -0.88% | – |
| ATRC | Exit | ATRICURE INC | $0 | – | -100,000 | -100.0% | -0.96% | – |
| ARIA | Exit | ARIAD PHARMACEUTICALS INC | $0 | – | -300,000 | -100.0% | -0.99% | – |
| BDSI | Exit | BIODELIVERY SCIENCES INTL IN | $0 | – | -175,000 | -100.0% | -1.01% | – |
| ISRG | Exit | INTUITIVE SURGICAL INC | $0 | – | -4,000 | -100.0% | -1.02% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -300,000 | -100.0% | -1.09% | – |
| VRX | Exit | VALEANT PHARMACEUTICALS INTL | $0 | – | -20,000 | -100.0% | -1.37% | – |
| QDEL | Exit | QUIDEL CORP | $0 | – | -100,000 | -100.0% | -1.39% | – |
| OPHT | Exit | OPHTHOTECH CORP | $0 | – | -65,000 | -100.0% | -1.40% | – |
| ISIS | Exit | ISIS PHARMACEUTICALS INCput | $0 | – | -50,000 | -100.0% | -1.48% | – |
| SYK | Exit | STRYKER CORP | $0 | – | -35,000 | -100.0% | -1.58% | – |
| UHS | Exit | UNIVERSAL HLTH SVCS INCcl b | $0 | – | -30,000 | -100.0% | -1.60% | – |
| AMAG | Exit | AMAG PHARMACEUTICALS INC | $0 | – | -80,000 | -100.0% | -1.64% | – |
| SLXP | Exit | SALIX PHARMACEUTICALS INC | $0 | – | -30,000 | -100.0% | -1.65% | – |
| KITE | Exit | KITE PHARMA INC | $0 | – | -60,000 | -100.0% | -1.66% | – |
| AIRM | Exit | AIR METHODS CORP | $0 | – | -85,000 | -100.0% | -1.80% | – |
| HZNP | Exit | HORIZON PHARMA PLC | $0 | – | -300,000 | -100.0% | -1.86% | – |
| INSYQ | Exit | INSYS THERAPEUTICS INC NEW | $0 | – | -100,000 | -100.0% | -2.02% | – |
| NVRO | Exit | NEVRO CORP | $0 | – | -115,000 | -100.0% | -2.13% | – |
| DEPO | Exit | DEPOMED INC | $0 | – | -300,000 | -100.0% | -2.32% | – |
| LJPC | Exit | LA JOLLA PHARMACEUTICAL CO | $0 | – | -286,053 | -100.0% | -2.53% | – |
| GILD | Exit | GILEAD SCIENCES INC | $0 | – | -65,000 | -100.0% | -2.94% | – |
| ISIS | Exit | ISIS PHARMACEUTICALS INCcall | $0 | – | -150,000 | -100.0% | -4.44% | – |
| SYK | Exit | STRYKER CORPcall | $0 | – | -100,000 | -100.0% | -4.53% | – |
| GILD | Exit | GILEAD SCIENCES INCcall | $0 | – | -125,000 | -100.0% | -5.65% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MIRATI THERAPEUTICS INC | 30 | Q3 2023 | 7.3% |
| ASCENDIS PHARMA A/S - ADR | 28 | Q3 2023 | 11.8% |
| BIOCRYST PHARMACEUTICALS INC | 25 | Q2 2023 | 2.4% |
| AMICUS THERAPEUTICS INC | 23 | Q3 2023 | 5.6% |
| SAREPTA THERAPEUTICS INC | 22 | Q3 2023 | 9.1% |
| SPDR SER TR | 20 | Q3 2022 | 16.9% |
| IOVANCE BIOTHERAPEUTICS INC | 18 | Q2 2023 | 5.5% |
| ROCKET PHARMACEUTICALS INC | 18 | Q2 2023 | 6.1% |
| SAGE THERAPEUTICS INC | 18 | Q1 2021 | 4.8% |
| IMMUNOMEDICS INC | 17 | Q2 2020 | 8.7% |
View Ghost Tree Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
| 13F-HR | 2022-02-16 |
| 13F-HR | 2021-11-15 |
View Ghost Tree Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.